130 related articles for article (PubMed ID: 32980534)
21. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
[TBL] [Abstract][Full Text] [Related]
22. The effect of metformin on breast cancer outcomes in patients with type 2 diabetes.
Oppong BA; Pharmer LA; Oskar S; Eaton A; Stempel M; Patil S; King TA
Cancer Med; 2014 Aug; 3(4):1025-34. PubMed ID: 24944108
[TBL] [Abstract][Full Text] [Related]
23. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity.
Romero IL; McCormick A; McEwen KA; Park S; Karrison T; Yamada SD; Pannain S; Lengyel E
Obstet Gynecol; 2012 Jan; 119(1):61-7. PubMed ID: 22183212
[TBL] [Abstract][Full Text] [Related]
24. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
25. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
26. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Wahlqvist ML; Lee MS; Hsu CC; Chuang SY; Lee JT; Tsai HN
Parkinsonism Relat Disord; 2012 Jul; 18(6):753-8. PubMed ID: 22498320
[TBL] [Abstract][Full Text] [Related]
27. Metformin therapy in patients with diabetes mellitus is associated with a reduced risk of vasculopathy and cardiovascular mortality after heart transplantation.
Ram E; Lavee J; Tenenbaum A; Klempfner R; Fisman EZ; Maor E; Ovdat T; Amunts S; Sternik L; Peled Y
Cardiovasc Diabetol; 2019 Sep; 18(1):118. PubMed ID: 31526382
[TBL] [Abstract][Full Text] [Related]
28. Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study.
Wu H; Walker J; Damhuis RA; Brewster DH; Wild SH;
Lung Cancer; 2016 Sep; 99():194-9. PubMed ID: 27565939
[TBL] [Abstract][Full Text] [Related]
29. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients.
Kincius M; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
Aging Male; 2020 Dec; 23(5):1333-1338. PubMed ID: 32410514
[TBL] [Abstract][Full Text] [Related]
30. Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan.
Tseng CH
Eur J Endocrinol; 2012 Sep; 167(3):409-16. PubMed ID: 22778198
[TBL] [Abstract][Full Text] [Related]
31. Metformin improves the outcomes in Chinese invasive breast cancer patients with type 2 diabetes mellitus.
Hui T; Shang C; Yang L; Wang M; Li R; Song Z
Sci Rep; 2021 May; 11(1):10034. PubMed ID: 33976288
[TBL] [Abstract][Full Text] [Related]
32. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
Tseng CH
J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
[TBL] [Abstract][Full Text] [Related]
33. Safety of Metformin in Psoriasis Patients With Diabetes Mellitus: A 17-Year Population-Based Real-World Cohort Study.
Su YJ; Chen TH; Hsu CY; Chiu WT; Lin YS; Chi CC
J Clin Endocrinol Metab; 2019 Aug; 104(8):3279-3286. PubMed ID: 30779846
[TBL] [Abstract][Full Text] [Related]
34. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin.
Hsu CC; Wahlqvist ML; Lee MS; Tsai HN
J Alzheimers Dis; 2011; 24(3):485-93. PubMed ID: 21297276
[TBL] [Abstract][Full Text] [Related]
35. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
[TBL] [Abstract][Full Text] [Related]
36. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
37. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies.
Chang SH; Wu LS; Chiou MJ; Liu JR; Yu KH; Kuo CF; Wen MS; Chen WJ; Yeh YH; See LC
Cardiovasc Diabetol; 2014 Aug; 13():123. PubMed ID: 25106079
[TBL] [Abstract][Full Text] [Related]
38. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
[TBL] [Abstract][Full Text] [Related]
39. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
40. Oral hypoglycaemic agents and the development of non-fatal cardiovascular events in patients with type 2 diabetes mellitus.
Hung YC; Lin CC; Wang TY; Chang MP; Sung FC; Chen CC
Diabetes Metab Res Rev; 2013 Nov; 29(8):673-9. PubMed ID: 23956007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
